☆ 4.7 Letter

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

BRITISH JOURNAL OF CANCER (2015)

期刊

BRITISH JOURNAL OF CANCER

卷 112, 期 11, 页码 1832-1833

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/bjc.2014.570

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer

Jiajia He, Fangmeng Fu, Wei Wang, Gangqin Xi, Wenhui Guo, Liqin Zheng, Wenjiao Ren, Lida Qiu, Xingxin Huang, Chuan Wang, Lianhuang Li, Deyong Kang, Jianxin Chen

Summary: TILs-score is identified as an independent prognostic factor for disease-free survival and overall survival in patients with breast cancer, particularly in the estrogen receptor-positive subgroup. Combining TILs-score with clinical factors improves predictive ability, especially for the estrogen receptor-positive subgroup.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Pathology

High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series

Michal Kunc, Rafal Peksa, Gabor Cserni, Ewa Izycka-Swieszewska, Aleksandra Lacko, Barbara Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Anna Szwajkosz, Wojciech Biernat, Elzbieta Senkus

Summary: This study conducted a comprehensive immunohistochemical re-evaluation of ER-/PgR+ breast cancer and confirmed the existence of this subgroup. It also identified high PgR expression as an adverse prognostic factor.

PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Oestrogen receptor low positive breast cancer: associations with prognosis

Anette H. Skjervold, Marit Valla, Anna M. Bofin

Summary: In this study, we examined the associations between levels of ER expression and tumour characteristics and prognosis in three large cohorts of BC patients. The results showed that ER Low Positive tumours were mainly found in Luminal B (HER2+) subtype and grade 3 tumours. The risk of death from BC was lower in ER Low Positive and ER ≥ 10% compared to ER-negative cases. Patients diagnosed in 1995 or later with ER Low Positive BCs had smaller, lower-grade tumours with lower proliferation status and similar prognosis compared to those with ER ≥ 10% tumours.

BREAST CANCER RESEARCH AND TREATMENT (2023)

添加到收藏夹

Review Oncology

Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/ HER2-negative early breast cancer: a systematic review and meta-analysis

Diogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, Lieveke Ameye, Marianne Paesmans, Michail Ignatiadis, Philippe Aftimos, Roberto Salgado, Evandro de Azambuja

Summary: High Ki-67 index is associated with worse survival outcomes in women with ER-positive/HER2-negative early breast cancer.

EUROPEAN JOURNAL OF CANCER (2023)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma

Jia Kang, Ming Su, Qiaoshi Xu, Chong Wang, Xiaohong Yuan, Zhengxue Han

Summary: The objective of this study was to evaluate the prognostic value of TSR and TB in OTSCC and establish a predictive model for the outcome of OTSCC patients. The results indicated that TSR was an independent risk factor for the prognosis of OTSCC patients and patients with stroma-rich had a worse long-term prognosis. The risk model combining TSR and TB showed valuable predictive power for the outcome of OTSCC patients.

ORAL DISEASES (2023)

添加到收藏夹

Article Oncology

Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer

Dandan Yan, Xianli Ju, Bin Luo, Feng Guan, Huihua He, Honglin Yan, Jingping Yuan

Summary: The tumor-stroma ratio (TSR) is an independent predictor for 5-year disease-free survival (5-DFS) in breast cancer, with low TSR associated with worse outcomes. This prognostic value is observed in different molecular subtypes of breast cancer as well.

BMC CANCER (2022)

添加到收藏夹

Article Oncology

AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer

Noorul Wahab, Michael Toss, Islam M. Miligy, Mostafa Jahanifar, Nehal M. Atallah, Wenqi Lu, Simon Graham, Mohsin Bilal, Abhir Bhalerao, Ayat G. Lashen, Shorouk Makhlouf, Asmaa Y. Ibrahim, David Snead, Fayyaz Minhas, Shan E. Ahmed Raza, Emad Rakha, Nasir Rajpoot

Summary: The study proposes an image-based prognostic marker for breast cancer that uses deep learning to objectively assess tumor heterogeneity. The marker demonstrates the ability to predict both patient survival and distant metastasis in early-stage breast cancer, with comparable accuracy to traditional manual assessment methods.

NPJ PRECISION ONCOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study

Hao Dang, Gabi W. van Pelt, Krijn J. C. Haasnoot, Yara Backes, Sjoerd G. Elias, Tom C. J. Seerden, Matthijs P. Schwartz, Bernhard W. M. Spanier, Wouter H. de Vos tot Nederveen Cappel, Jeroen D. van Bergeijk, Koen Kessels, Joost M. J. Geesing, John N. Groen, Frank ter Borg, Frank H. J. Wolfhagen, Cornelis A. Seldenrijk, Mihaela G. Raicu, Anya N. Milne, Anja U. G. van Lent, Lodewijk A. A. Brosens, G. Johan A. Offerhaus, Peter D. Siersema, Rob A. E. M. Tollenaar, James C. H. Hardwick, Lukas J. A. C. Hawinkels, Leon M. G. Moons, Miangela M. Lacle, Wilma E. Mesker, Jurjen J. Boonstra

Summary: This study investigated whether the tumour-stroma ratio (TSR) can predict clinical outcomes in patients with early colorectal cancer. The results showed that tumors with high stromal content were not associated with adverse outcomes.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

添加到收藏夹

Article Pathology

Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens

Zsofia Karancsi, Sophie C. Hagenaars, Kristof Nemeth, Wilma E. Mesker, Anna Maria Tokes, Janina Kulka

Summary: The purpose of this study is to determine whether the tumour-stroma ratio (TSR) evaluated in breast cancer core biopsies is representative of the whole tumour. The study investigates different TSR scoring methods, their reproducibility, and the association with clinicopathological characteristics. The results show that TSR is easy to determine and reproducible, and is associated with multiple clinicopathological characteristics of breast cancer.

VIRCHOWS ARCHIV (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Prognostic Significance of the Microbiome and Stromal Cells Phenotype in Esophagus Squamous Cell Carcinoma

Olga Kovaleva, Polina Podlesnaya, Madina Rashidova, Daria Samoilova, Anatoly Petrenko, Valeria Mochalnikova, Vladimir Kataev, Yuri Khlopko, Andrey Plotnikov, Alexei Gratchev

Summary: Esophageal cancer, especially squamous cell carcinoma, shows significant correlations between microbiome composition and tumor infiltrating phenotypes. Specific types of tumors have higher bacterial burdens, with different microbial components associated with disease prognosis.

BIOMEDICINES (2021)

添加到收藏夹

Article Medicine, General & Internal

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy

Nuria Chic, Francesco Schettini, Fara Braso-Maristany, Esther Sanfeliu, Barbara Adamo, Maria Vidal, Debora Martinez, Patricia Galvan, Blanca Gonzalez-Farre, Javier Cortes, Joaquin Gavila, Cristina Saura, Mafalda Oliveira, Sonia Pernas, Olga Martinez-Saez, Jesus Soberino, Eva Ciruelos, Lisa A. Carey, Montserrat Munoz, Charles M. Perou, Tomas Pascual, Meritxell Bellet, Aleix Prat

Summary: Chemotherapy has different biological effects on patients with hormone receptor-positive breast cancer with different menopausal statuses. Specific estrogen-regulated genes exhibited varied expression levels under different treatment regimens in these patients.

EBIOMEDICINE (2021)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Prognostic value of tumor-stroma ratio in oral carcinoma: Role of cancer-associated fibroblasts

Zhengjun Shang, Jingjian Qiu, Erhui Jiang

Summary: This study confirms the prognostic value of TSR in oral squamous cell carcinoma (OSCC) and demonstrates the contribution of cancer-associated fibroblasts (CAFs)-stroma ratio (CSR) to the prognostic value of TSR.

ORAL DISEASES (2023)

添加到收藏夹

Article Oncology

Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer

Nazia Riaz, Samantha Burugu, Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Torsten O. Nielsen

Summary: Experimental evidence suggests that CSF-1/CSF-1R signaling plays a role in attracting macrophages and promoting cancer cell spread. High CSF-1R expression on breast cancer cells is associated with poor survival, especially in hormone receptor-positive cases. Inhibitors of CSF-1R are being investigated in clinical trials and may benefit patients in combination with immunotherapies.

CANCERS (2021)

添加到收藏夹

Review Oncology

Prognostic Efficacy of Tumor-Stroma Ratio in Women With Breast Cancer: A Meta-Analysis of Cohort Studies

Pengli Jiang, Yulong Chen, Bin Liu

Summary: Tumor-stroma ratio (TSR) is considered an emerging prognostic predictor in breast cancer, with patients having high TSR tumors showing worse survival outcomes. Studies support TSR as a prognostic factor in breast cancer patients.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Tumor-Stroma Ratio in Basaloid and Conventional Laryngeal Squamous Cell Carcinoma: Prognostic Significance and Concordance in Paired Biopsies and Surgical Samples

Gino Marioni, Stefano Taboni, Marta Sbaraglia, Leonardo Franz, Tommaso Saccardo, Anna Colombo, Camilla Zimello, Anna Chiara Frigo, Marco Ferrari, Lara Alessandrini

Summary: This retrospective study compares the tumor-stroma ratio between laryngeal basaloid squamous cell carcinomas (BSCCs) and conventional squamous cell carcinomas (cSCCs). The results show that the tumor-stroma ratio is prognostic for disease-free survival in cSCCs but not in BSCCs. BSCCs have a poorer prognosis compared to cSCCs.

CANCERS (2023)

添加到收藏夹

Article Obstetrics & Gynecology

Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer

Elke E. M. Peters, Alicia Leon-Castillo, Estrid Hogdall, Marie Boennelycke, Vincent T. H. B. M. Smit, Claus Hogdall, Carien L. Creutzberg, Tjalling Bosse, Remi A. Nout, Gitte Ortoft

Summary: This study aimed to determine whether the extent of lymphovascular space invasion (LVSI) can serve as a prognostic factor in patients with high-risk endometrial cancer (HREC). The study found that substantial LVSI is an independent adverse prognostic factor for lymph node and distant metastases in HREC patients, leading to reduced survival. Therefore, the extent of LVSI should be incorporated into routine pathology reports to guide the appropriate choice of adjuvant treatment.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)

添加到收藏夹

Article Obstetrics & Gynecology

Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer

Elke E. M. Peters, Alicia Leon-Castillo, Vincent T. H. B. M. Smit, Marie Boennelycke, Estrid Hogdall, Claus Hogdall, Carien Creutzberg, Ina M. Jurgenliemk-Schulz, Jan J. Jobsen, Jan Willem M. Mens, Ludy C. H. W. Lutgens, Elzbieta M. Van der Steen-Banasik, Gitte Ortoft, Tjalling Bosse, Remi Nout

Summary: This study aimed to improve the accuracy of measuring clinically meaningful LVSI by quantitatively analyzing the correlation between LVSI and the risk of pelvic lymph node recurrence in EC. The study found that a numeric threshold (>= 4 LVSI-involved vessels in at least one H&E slide) can be used to define clinically relevant LVSI in EC.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

Alicia Leon-Castillo, Nanda Horeweg, Elke E. M. Peters, Tessa Rutten, Natalja ter Haar, Vincent T. H. B. M. Smit, Cor D. Kroon, Marie Boennelycke, Estrid Hogdall, Claus Hogdall, Remi R. A. Nout, Carien L. Creutzberg, Gitte Ortoft, Tjalling Bosse

Summary: The study evaluates the clinical outcome of molecular subgroups in high-grade endometrial cancer (EC) patients staged with lymphadenectomy and those without adjuvant treatment. The molecular classification has strong prognostic value, independent of clinicopathological factors. The unfavorable prognosis of early-stage p53abn EC is not due to undetected lymph node metastasis, and the indolent behavior of POLEmut EC is independent of adjuvant treatment.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Cell Biology

Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer

Liesbeth M. Hondelink, Melek Huyuk, Pieter E. Postmus, Vincent T. H. B. M. Smit, Sami Blom, Jan H. von der Thusen, Danielle Cohen

Summary: A new deep learning-based PD-L1 TPS algorithm was developed to assess PD-L1 expression in daily routine diagnostic cases, showing similar concordance with pathologists and meeting the requirements for functioning as a 'scoring assistant'. The algorithm had similar concordance with the reference score as pathologists had with one another, successfully validated on routine diagnostic whole slide images (WSIs) with detailed visual feedback.

HISTOPATHOLOGY (2022)

添加到收藏夹

Article Oncology

The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer

Rogier Butter, Liesbeth M. Hondelink, Lisette van Elswijk, Johannes L. G. Blaauwgeers, Elisabeth Bloemena, Rieneke Britstra, Nicole Bulkmans, Anna Lena van Gulik, Kim Monkhorst, Mathilda J. de Rooij, Ivana Slavujevic-Letic, Vincent T. H. B. M. Smit, Ernst-Jan M. Speel, Erik Thunnissen, Jan H. von der Thusen, Wim Timens, Marc J. van de Vijver, David C. Y. Yick, Aeilko H. Zwinderman, Danielle Cohen, Nils A. 't Hart, Teodora Radonic

Summary: This study demonstrates the impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of immunostaining in the context of PD-L1 in NSCLC.

LUNG CANCER (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

Nanda Horeweg, Hagma H. Workel, Dominik Loiero, David N. Church, Lisa Vermij, Alicia Leon-Castillo, Ricki T. Krog, Stephanie M. de Boer, Remi A. Nout, Melanie E. Powell, Linda R. Mileshkin, Helen MacKay, Alexandra Leary, Naveena Singh, Ina M. Juergenliemk-Schulz, Vincent T. H. B. M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn

Summary: B-cells and tertiary lymphoid structures (TLS) play critical roles in endometrial cancer (EC). L1CAM is identified as a marker for mature TLS and the presence of TLS is associated with favorable prognosis in EC patients.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Oncology

Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and-2 trials

A. S. V. M. van den Heerik, K. T. S. Aiyer, E. Stelloo, I. M. Juergenliemk-Schulz, L. C. H. W. Lutgens, J. J. Jobsen, J. W. M. Mens, E. M. van der Steen-Banasik, C. L. Creutzberg, V. T. H. B. M. Smit, N. Horeweg, T. Bosse

Summary: This study aimed to investigate the association between MELF invasion and clinicopathological and molecular characteristics of endometrial carcinoma, as well as its prognostic relevance in early-stage low/intermediate risk EC.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Pathology

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Lisa Vermij, Alicia Leon-Castillo, Naveena Singh, Melanie E. Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T. H. B. M. Smit, Emma J. Crosbie, Alexandra Leary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse

Summary: This study comprehensively investigated the relationship between abnormal p53 immunohistochemical (IHC) patterns and clinicopathological and molecular features. The presence of subclonal abnormal p53 expression was found to be a strong indicator for POLEmut and/or MMRd EC. Awareness of abnormal p53 IHC patterns is crucial for correct EC molecular classification.

MODERN PATHOLOGY (2022)

添加到收藏夹

Review Pathology

Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis

K. T. S. Aiyer, T. Doeleman, N. A. Ryan, M. Nielsen, E. J. Crosbie, V. T. H. B. M. Smit, H. Morreau, J. J. Goeman, T. Bosse

Summary: This study explored the feasibility of using immunohistochemical staining with PMS2 and MSH6 as a substitute, which has advantages in terms of cost and time saving. The high detection rate of MMRd using the two-antibody testing algorithm supports its use in clinical practice.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Lisa J. Vermij, Jan J. Jobsen, Alicia Leon-Castillo, Mariel Brinkhuis, Suzan E. Roothaan, Melanie E. M. Powell, Stephanie M. de Boer, Pearly R. Khaw, Linda R. Mileshkin, Anthony Fyles, Alexandra Leary, Catherine M. Genestie, Ina M. J. Jurgenliemk-Schulz, Emma J. J. Crosbie, Helen J. Mackay, Hans. W. A. Nijman, Remi A. Nout, Vincent T. H. B. M. L. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling M. Bosse, Stephanie M. de Boer

Summary: This study aimed to investigate whether adding hormone receptor expression, L1CAM expression or CTNNB1 status can improve the accuracy of risk assessment in endometrial cancer (EC). The study found that the expression of ER, PR, L1CAM, and CTNNB1 did not have independent prognostic value in EC, while age, stage, and adjuvant chemotherapy had an independent impact on the risk of recurrence. However, in high-risk EC of non-serous/mixed papillary (NSMP) subgroup, ER positivity was independently associated with a reduced risk of recurrence.

BRITISH JOURNAL OF CANCER (2023)

添加到收藏夹

Article Oncology

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

T. Bosse, C. L. Creutzberg, E. J. Crosbie, K. Han, N. Horeweg, A. Leary, J. R. Kroep, J. N. McAlpine, M. E. Powell, F. Blanc-Durand, M. de Bruyn, D. N. Church, V. H. Koelzer, S. Kommoss, N. Singh, A. Bardet, N. Counsell, H. Putter, D. Tu, R. Edmondson, C. Gordon, J. Ledermann, P. Morice, H. MacKay, H. Nijman, R. A. Nout, V. T. H. B. M. Smit, H. White, J. Alexandre, S. M. de Boer, I Boere, R. Cooper, J. L. Ethier, J. S. Frenel, J. McGrane, A. Taylor, S. Welch, A. M. Westermann, H. Dijcker-van der Linden, L. Farrelly, A. Feeney, M. Kaya, W. Liu, A. Melis, F. Ngadjeua-Tchouatieu, W. Parulekar, K. Verhoeven-Adema, RAINBO Res Consortium

Summary: The RAINBO program aims to investigate molecular class-directed adjuvant treatment strategies for endometrial cancer, with the goal of improving clinical outcomes and reducing toxicity. It consists of four international clinical trials and an overarching research program to advance knowledge of predictive and prognostic markers.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

添加到收藏夹

Meeting Abstract Medicine, Research & Experimental

Five-Year Universal Sequencing of BRCA1/2 and Homologous Recombination-Related Genes in Epithelial Ovarian Carcinoma; Is Histotype Directed Testing Justified?

Claire Kramer, Nienke Solleveld, Giacomo Santandrea, Marthe de Jonge, Hans Marten Hazelbag, Marjolein Kagie, Elisabeth Ahsmann, Judith Kroep, Nienke van der Stoep, Cor de Kroon, Katja Gaarenstroom, Tom van Wezel, Vincent Smit, Christi van Asperen, Maaike Vreeswijk, Tjalling Bosse

LABORATORY INVESTIGATION (2022)

添加到收藏夹

Meeting Abstract Pathology

Prognostic Relevance of FIGO Grading is Limited to NSMP Endometrial Carcinomas

Lisa Vermij, Jan Jobsen, Mariel Brinkhuis, Suzan Roothaan, Alicia Leon del Castillo, Naveena Singh, Linda Mileshkin, Melanie Powell, Prafull Ghatage, C. Meg Mclachlin, Alexandra Leary, Catherine Genestie, Hans Nijman, Harry Hollema, Ina Jurgenliemk-Schulz, Remi Nout, Vincent Smit, Stephanie de Boer, Carien Creutzberg, Nanda Horeweg, Tjalling Bosse

MODERN PATHOLOGY (2022)

添加到收藏夹

Meeting Abstract Pathology

Five-Year Universal Sequencing of BRCA1/2 and Homologous Recombination-Related Genes in Epithelial Ovarian Carcinoma; Is Histotype Directed Testing Justified?

Claire Kramer, Nienke Solleveld, Giacomo Santandrea, Marthe de Jonge, Hans Marten Hazelbag, Marjolein Kagie, Elisabeth Ahsmann, Judith Kroep, Nienke van der Stoep, Cor de Kroon, Katja Gaarenstroom, Tom van Wezel, Vincent Smit, Christi van Asperen, Maaike Vreeswijk, Tjalling Bosse

MODERN PATHOLOGY (2022)

添加到收藏夹

Meeting Abstract Pathology

AIRMEC - an Artificial Intelligence Model to Predict the Molecular Endometrial Cancer Classification from H&E Images

Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Jan Jobsen, Mariel Brinkhuis, Suzan Roothaan, Ina Jurgenliemk-Schulz, Ludy Lutgens, Remi Nout, Elzbieta van der Steen-Banasik, Stephanie de Boer, Melanie Powell, Naveena Singh, Linda Mileshkin, Helen Mackay, Alexandra Leary, Hans Nijman, Vincent Smit, Carien Creutzberg, Nanda Horeweg, Viktor Kolzer, Tjalling Bosse

MODERN PATHOLOGY (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.